Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Surg Case Rep ; 109: 108599, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37544098

ABSTRACT

INTRODUCTION AND IMPORTANCE: Primary and metastatic carcinoma of the small intestine are rare. While most of these malignancies are adenocarcinomas, squamous cell carcinoma (SCC) of the gastrointestinal tract is uncommon. We present a case report of a rare occurrence of skin SCC metastasizing to the ileum, highlighting diagnostic challenges and clinical implications. CASE PRESENTATION: An 83-year-old female had a history of cutaneous SCC excision in the right temporal region two years prior to the current emergency department visit, followed by metastatic recurrence in a right intra-parotid lymph node treated with radiotherapy. The patient exhibited septic shock and an acute abdomen, and an abdominal computed tomography scan revealed signs of intestinal perforation. Emergency exploratory laparotomy confirmed purulent peritonitis and perforation of the terminal ileum. Subsequently, a 20 cm intestinal resection was performed. Histopathological examination of the resected specimen revealed a 4 cm perforated SCC of the small intestine (pT4 pN0 L0 V1 Pn0 R0). CLINICAL DISCUSSION: Metastases of the small intestine are rare. The primary sites for these metastases are typically the uterus, cervix, colon, lung, breast, or melanoma. SCC of the small intestine is particularly rare and poses challenges in diagnosis owing to non-specific symptoms. The prognosis for SCC of the small intestine is generally poor, and the potentially aggressive behavior of some skin SCC emphasizes the need for increased awareness and vigilance in managing such cases. CONCLUSION: This case report underscores the importance of considering metastatic disease in the small bowel of patients with a history of skin SCC who present with new-onset abdominal symptoms.

2.
Am J Case Rep ; 19: 1386-1392, 2018 Nov 22.
Article in English | MEDLINE | ID: mdl-30464167

ABSTRACT

BACKGROUND Although diverticular disease is well described and treated in daily clinical practice, there are cases that attract great interest because of their complexity and difficulty in management. Herein, we describe a rare case of colo-colonic fistula-complicated diverticulitis that necessitated urgent surgical intervention. CASE REPORT A 76-year-old female patient with a known history of diverticular disease of the sigmoid colon presented in the Emergency Department for evaluation of left lower quadrant abdominal pain. The clinical and radiological examinations revealed a recurrent episode of acute diverticulitis of the sigmoid colon. However, it was of great interest that we detected a sigmoido-cecal fistula in the abdominal computed tomography (CT). The patient was admitted to the hospital for conservative treatment. After 48 hours, the patient's clinical status deteriorated, with pain aggravation, abdominal distension, bloating, and metallic bowel sounds. The simple abdominal x-ray revealed large-bowel obstruction and the CT demonstrated worsening inflammation of the sigmoid colon. An exploratory laparotomy revealed an inflamed dolichol-sigmoid colon forming a fistulous tract with the cecum and thus, mimicking a closed loop obstruction. The sigmoid colon was transected en bloc with the sigmoido-cecal fistula and a Hartmann's procedure was performed. CONCLUSIONS This case is extremely unusual as the patient presented at the same time two complications of diverticular disease, both obstruction and this rare formation of sigmoido-cecal fistula. It is presented in order to acquaint surgeons with the possibility of an unexpected course of this disease which indeed necessitates an individualized management.


Subject(s)
Cecal Diseases/etiology , Diverticulitis, Colonic/complications , Intestinal Fistula/diagnosis , Intestinal Fistula/etiology , Intestinal Obstruction/etiology , Sigmoid Diseases/etiology , Aged , Cecal Diseases/diagnosis , Cecal Diseases/surgery , Diverticulitis, Colonic/diagnosis , Diverticulitis, Colonic/surgery , Female , Humans , Intestinal Fistula/surgery , Intestinal Obstruction/diagnosis , Intestinal Obstruction/surgery , Sigmoid Diseases/diagnosis , Sigmoid Diseases/surgery , Tomography, X-Ray Computed
3.
J Coll Physicians Surg Pak ; 28(9): 714-716, 2018 Sep.
Article in English | MEDLINE | ID: mdl-30158041

ABSTRACT

Desmoid tumor, recently renamed as desmoid type fibromatosis, is an uncommon neoplasm. The mesentery is the usual origin of intra-abdominal desmoid-type fibromatosis and despite the fact there is no metastatic potential, it can infiltrate adjacent organs. There etiology remains unknown, preoperative diagnosis is difficult and differential diagnosis includes among other gastrointestinal stromal tumor (GIST). In resectable tumors, the mainstay of treatment is surgical resection with at least clean microscopic margins. We present a case of a 51-year lady who presented with a 6.2 x 4.5 x 3.3 cm neoplasm in the anatomic area of the greater gastric curvature, the splenic hilum and the tail of the pancreas that was diagnosed as GIST on the CT scan. The patient was submitted to laparoscopic excision of the tumor and histopathological examination revealed desmoid type fibromatosis of the splenic hilum infiltrating the spleen, pancreatic tale and greater gastric curvature. According to the authors' knowledge, this is the first reported case of a sporadic splenic desmoid tumor, which has been treated successfully by laparoscopic en block resection.


Subject(s)
Fibromatosis, Aggressive/surgery , Laparoscopy/methods , Spleen/diagnostic imaging , Splenic Neoplasms/surgery , Diagnosis, Differential , Female , Fibromatosis, Aggressive/diagnosis , Gastrointestinal Neoplasms/diagnosis , Gastrointestinal Stromal Tumors , Humans , Stomach Neoplasms/pathology , Tomography, X-Ray Computed
4.
J Cancer ; 9(2): 232-238, 2018.
Article in English | MEDLINE | ID: mdl-29344268

ABSTRACT

Colorectal cancer still remains the third cause of cancer death among cancer patients. Early diagnosis is crucial and they can be either endoscopic or with blood biomarkers. Endoscopic methods consist of gastroscopy and colonoscopy, however; in recent years, endoscopic ultrasound is being used. The microenvironment is very important for the successful delivery of the treatment. Several proteins and hormones play a crucial role in the efficiency of the treatment. In the current mini review we will focus on interferon-γ.

5.
Anticancer Res ; 37(5): 2323-2334, 2017 05.
Article in English | MEDLINE | ID: mdl-28476798

ABSTRACT

BACKGROUND: The Notch pathway has been implicated in triple-negative breast cancer (TNBC). Herein, we studied the subcellular localization of the less investigated Notch2 and Notch3 and that of the Jagged1 (Jag1) ligand in patients with operable TNBC. PATIENTS AND METHODS: We applied immunohistochemistry for Notch2, Notch3 and Jag1 in 333 tumors from TNBC patients treated with adjuvant anthracycline-based chemotherapy. We evaluated cytoplasmic (c), membranous (m) and nuclear (n) protein localization. RESULTS: c-Notch2 (35% positive tumors), c-Notch3 (63%), c-Jag1 (43%), m-Notch3 (23%) and n-Jag1 (17%) were analyzed individually and by using hierarchical clustering for prognostic evaluation. Upon multivariate analysis, compared to high m-Notch3 in the absence of n-Jag1 (cluster 4), all other marker combinations (clusters 1, 2, 3) conferred significantly higher risk for relapse (p<0.05). CONCLUSION: Specific Notch3 and Jag1 subcellular localization patterns may provide clues for the behavior of the tumors and potentially for Jag1 targeting in TNBC patients.


Subject(s)
Jagged-1 Protein/metabolism , Receptor, Notch2/metabolism , Receptor, Notch3/metabolism , Triple Negative Breast Neoplasms/metabolism , Anthracyclines/therapeutic use , Antineoplastic Agents/therapeutic use , Cell Membrane/metabolism , Cell Nucleus/metabolism , Cytoplasm/metabolism , Female , Humans , Middle Aged , Prognosis , Triple Negative Breast Neoplasms/drug therapy
6.
Rom J Morphol Embryol ; 57(1): 277-81, 2016.
Article in English | MEDLINE | ID: mdl-27151721

ABSTRACT

UNLABELLED: Heterotopic mesenteric ossification is a rare clinical entity with less than 40 reported cases. Moreover, heterotopic mesenteric ossification around a stoma is described in fewer cases. CASE PRESENTATION: An 81-year-old male patient, who underwent a sigmoidectomy two years ago for a sigmoid colon cancer, was admitted in our Department in order to be investigated for a local recurrence of his disease. Because of unresectable pelvic lesions, the patient was taken in the operating room for a palliative double barrel ileostomy. The patient presented two weeks after the ileostomy clinical signs suggesting its obstruction. A revision of the ileostomy is performed. Macroscopically, the end part of the ileostomy was inflamed and resected. Histological findings revealed heterotopic ossification of the mesentery. CONCLUSIONS: The surgeon should be alert to the possibility of heterotopic ossification, especially within a previously operated wound and be prepared for the difficulties it may cause during reopening of an incision, during the operation itself, at closure of the wound and, if not removed, also in the postoperative setting.


Subject(s)
Ileostomy/adverse effects , Mesentery/pathology , Myositis Ossificans/etiology , Ossification, Heterotopic/etiology , Aged, 80 and over , Bone and Bones/pathology , Fibroblasts/pathology , Humans , Ileum/pathology , Male , Myositis Ossificans/pathology , Ossification, Heterotopic/pathology
7.
J Surg Case Rep ; 2014(12)2014 Dec 08.
Article in English | MEDLINE | ID: mdl-25487371

ABSTRACT

Primary squamous cell carcinoma (SCC) of the thyroid gland is a very rare entity representing <1% of all primary carcinomas of the thyroid gland with a very poor prognosis. We report a rare case of a 65-year-old woman with SCC of the thyroid gland, emphasizing the postoperative complications and poor prognosis of these patients. Surgical excision of primary SCC of the thyroid gland when possible is the optimal therapy. Chemo- and radiotherapy rarely have place in its treatment as this malignancy has a poor response to chemotherapy and in many cases is radio-resistant. Median survival of these patients is around 6 months.

SELECTION OF CITATIONS
SEARCH DETAIL
...